Jefferies Financial Group’s Ventyx Biosciences VTYX Stock Holding History

Jefferies Financial Group’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,750	Closed	-$214K	–	2242
2025 Q4	$214K	Sell	23,750 -10,350	-30%	-$77.3K	﹤0.01%	1605
2025 Q3	$106K	Buy	+34,100	New	+$90.3K	﹤0.01%	1333
2023 Q4	–	Sell	-273,574	Closed	-$9.5M	–	2027
2023 Q3	$9.5M	Buy	273,574 +150,000	+121%	+$5.19M	0.09%	176
2023 Q2	$4.05M	Sell	123,574 -321,400	-72%	-$11.1M	0.04%	406
2023 Q1	$14.9M	Sell	444,974 -25,052	-5%	-$974K	0.12%	143
2022 Q4	$15.4M	Buy	+470,026	New	+$13.9M	0.11%	154

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jefferies Financial Group's VTYX Position: Q1 2026 in Review

Jefferies Financial Group sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 23,750 shares — an estimated $214K sold.

Jefferies Financial Group first reported a position in VTYX in Q4 2022 and held it in 6 quarters. The position peaked at $15.4M in Q4 2022. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Jefferies Financial Group reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Jefferies Financial Group sold 23,750 Ventyx Biosciences shares in Q1 2026, an estimated $214K.
Jefferies Financial Group first reported a position in Ventyx Biosciences in Q4 2022 and held it in 6 quarters.
Jefferies Financial Group's Ventyx Biosciences position peaked at $15.4M in Q4 2022.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.